Although pancreatic CSCs were described nearly ten years ago as CD44+/ CD24+/EpCAM+ cells [3] or CD133+ cells [4], no study has determined the co-expression of all of these markers in PDAC either directly in the tumor samples or in the human PDAC cell lines derived from primary tumors. This evidence concerns the gene EPCAM and neoplasm.